G1 Therapeutics (GTHX) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

GTHX is expected to report earnings to fall 10.60% to -8 cents per share on October 30

G1 Therapeutics GTHX Stock Earnings Reports

Q3'24

Est.

$-0.09

Q2'24

Beat

by $0.07

Q1'24

Est.

$-0.20

Q4'23

Beat

by $0.07

Q3'23

Missed

by $0.01

The last earnings report on August 08 showed earnings per share of -10 cents, beating the estimate of -16 cents. With 1.27M shares outstanding, the current market capitalization sits at 377.22M.

View a ticker or compare two or three

Compare

GTHX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GTHX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GTHX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drugs for cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

700 Park Offices Drive

Phone

+1 919 213-9835

Employees

100

Web

https://www.g1therapeutics.com